Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase(R) Provides Update on Bladder Cancer Clinical Study

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Oct 17, 2023 7:50am

221 Views

Post# 35686744

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Provides Update on Bladder Cancer Clinical Study

I believe the those timelines are the same, i believe we will get BTD and AA very soon which will change things drastically, JV possibly in the talks now, but waiting to get BTD before things heat up. Our results are too good to delay this treatment for the poor patients who drastically need it, one thing is for sure, Roger going to optimize his financial stake one way or the other

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project